Background: Phenotypically lacto-N-biosidase-positive Bifidobacterium longum JCM1217 does not possess a gene homologous to previously identified lacto-N-biosidase.
Results: Hypothetical proteins BLLJ_1505 and BLLJ_1506 encode lacto-N-biosidase and its designated chaperone, respectively.
Conclusion: The enzyme showed unique and unexpected substrate specificity.
Significance: The enzyme is important for understanding how B. longum consumes human milk oligosaccharides and also may serve as a new tool in glycobiology.
Keywords: Bacterial Metabolism, Carbohydrate Metabolism, Glycobiology, Glycoside Hydrolases, Microbiology, Oligosaccharide
Abstract
Infant gut-associated bifidobacteria possess species-specific enzymatic sets to assimilate human milk oligosaccharides, and lacto-N-biosidase (LNBase) is a key enzyme that degrades lacto-N-tetraose (Galβ1–3GlcNAcβ1–3Galβ1–4Glc), the main component of human milk oligosaccharides, to lacto-N-biose I (Galβ1–3GlcNAc) and lactose. We have previously identified LNBase activity in Bifidobacterium bifidum and some strains of Bifidobacterium longum subsp. longum (B. longum). Subsequently, we isolated a glycoside hydrolase family 20 (GH20) LNBase from B. bifidum; however, the genome of the LNBase+ strain of B. longum contains no GH20 LNBase homolog. Here, we reveal that locus tags BLLJ_1505 and BLLJ_1506 constitute LNBase from B. longum JCM1217. The gene products, designated LnbX and LnbY, respectively, showed no sequence similarity to previously characterized proteins. The purified enzyme, which consisted of LnbX only, hydrolyzed via a retaining mechanism the GlcNAcβ1–3Gal linkage in lacto-N-tetraose, lacto-N-fucopentaose I (Fucα1–2Galβ1–3GlcNAcβ1–3Galβ1–4Glc), and sialyllacto-N-tetraose a (Neu5Acα2–3Galβ1–3GlcNAcβ1–3Galβ1–4Gal); the latter two are not hydrolyzed by GH20 LNBase. Among the chromogenic substrates examined, the enzyme acted on p-nitrophenyl (pNP)-β-lacto-N-bioside I (Galβ1–3GlcNAcβ-pNP) and GalNAcβ1–3GlcNAcβ-pNP. GalNAcβ1–3GlcNAcβ linkage has been found in O-mannosyl glycans of α-dystroglycan. Therefore, the enzyme may serve as a new tool for examining glycan structures. In vitro refolding experiments revealed that LnbY and metal ions (Ca2+ and Mg2+) are required for proper folding of LnbX. The LnbX and LnbY homologs have been found only in B. bifidum, B. longum, and a few gut microbes, suggesting that the proteins have evolved in specialized niches.
Introduction
Infant intestinal microflora develops from a tripartite relationship between mother's milk, infant, and bacteria, and it is generally accepted that the microbiota in the intestines of breast-fed infants are rich in particular bifidobacterial species, such as Bifidobacterium breve, Bifidobacterium bifidum, and Bifidobacterium longum subsp. longum/infantis (collectively termed infant gut-associated bifidobacteria) (1, 2). These species/subspecies dominate in the gut ecosystem within a week after birth and continue their predominance until weaning, when the gut microflora become adult-like (1). For this reason, human milk has long been considered to contain bifidogenic compounds (3–6).
Recent research indicates that oligosaccharides (human milk oligosaccharides; HMOs)2 are responsible for the bifidogenic effect of human milk. Present at concentrations between 10 and 20 g/liter, HMOs constitute the third most abundant solid component in breast milk after lactose (Lac) and lipids but have apparently no nutritional value for infants (7–9). HMOs are characterized by their complex structures. To date, 115 HMO structures, classified into 13 core structures, have been determined (9). The core structures consist of Lac, at the reducing end, elongated by β1–3-linked lacto-N-biose I (Galβ1–3GlcNAc, LNB, type-1 chain) and/or β1–3/6-linked N-acetyllactosamine (Galβ1–4GlcNAc, LacNAc, type-2 chain) (10) and are frequently modified by fucose and sialic acid residues via α1–2/3/4 and α2–3/6 linkages, respectively (3, 9). Among the different HMO structures, four molecular species, namely 2′-fucosyllactose (Fucα1–2Galβ1–4Glc), lacto-N-tetraose (LNT, Galβ1–3GlcNAcβ1–3Galβ1–4Glc), lacto-N-fucopentaose I (LNFP I, Fucα1–2Galβ1–3GlcNAcβ1–3Galβ1–4Glc), and lacto-N-difucohexaose I (Fucα1–2Galβ1–3(Fucα1–4)GlcNAcβ1–3Galβ1–4Glc), are most abundantly present and comprise more than 50% of the total oligosaccharides, unless the milk is derived from non-secretor or Lewis-negative subjects (9, 10). The latter three structures reveal an abundance of type-1 chains in the HMOs (see supplemental Fig. S1). This composition is unique to HMOs and has not been observed in other mammalian milk oligosaccharides, including those of anthropoids (9). This uniqueness may explain why infant gut-associated bifidobacteria are equipped with specific enzymatic sets that are specifically involved in assimilation of type-1 HMOs (as described below).
Among the infant gut-associated bifidobacteria, B. bifidum and B. longum subsp. infantis (simply designated B. infantis in this study) have been thoroughly studied because they grow substantially on medium containing HMOs as the sole carbon source (OD600 > 1.5) (11, 12). B. bifidum produces a repertoire of secretory enzymes for HMO degradation (supplemental Fig. S1). 1,2-α-l-Fucosidase, 1,3–1,4-α-l-fucosidase, and sialidase act initially to uncover the core structure of HMOs (13, 14, 15, 16). The type-1 chain is then digested by lacto-N-biosidase (LNBase) to liberate LNB, whereas the type-2 chain is degraded sequentially by β-galactosidase and β-N-acetylglucosaminidase to liberate Gal and GlcNAc, respectively (17, 18). Subsequently, LNB is preferentially imported into the bifidobacterial cells via the GNB (galacto-N-biose)/LNB transporter for further degradation (19, 20, 21). Lac and monosaccharides are also utilized, although some remain unconsumed during growth in HMO-containing medium (12). The GNB/LNB transporter is found solely in infant gut-associated bifidobacteria (supplemental Fig. S1). Because LNB selectively stimulates these species among the different gut microbes, it is considered a key instigator of bifidogenic effect (22). B. infantis also possesses the GNB/LNB pathway, but it has evolved a different strategy for HMO assimilation (11). This organism apparently imports all classes of HMOs in their intact forms and degrades them by exo-glycosidases in the cytoplasm (23, 24, 25). Therefore, B. infantis shows no preference for type-1 chain, although cytoplasmic digestion inevitably involves LNT β-1,3-galactosidase (type-1-specific), which is exclusively found in infant gut-associated bifidobacteria (23). It should be mentioned that most β-galactosidases are incapable of hydrolyzing type-1 chains.
In contrast to the two species mentioned above, the other infant gut-associated bifidobacteria, B. longum subsp. longum (referred to as B. longum) and B. breve have received far less attention, perhaps because they grow poorly on HMO-containing medium (OD600 < 0.3) (12, 26). Because more than 70% of HMOs are fucosylated (i.e. derived from secretor and Lewis-positive donors), the poor growth ability of the two species may be attributable to a lack of 1,2-α-l-fucosidase and 1,3–1,4-α-l-fucosidase (5). Accordingly, when B. breve JCM1192T and B. longum JCM1217T are inoculated in HMO-containing media, they consume LNT only (12). In the spent medium of B. breve JCM1192 cultures, no degradation products (mono-, di-, and trisaccharides) of LNT have been detected, whereas in the culture supernatant of B. longum JCM1217, Lac appears transiently as LNT decreases. Thus, whereas B. breve JCM1192 imports intact LNT as does B. infantis, LNT consumption by B. longum JCM1217 should involve secretory LNBase and the subsequent GNB/LNB pathway (supplemental Fig. S1). Indeed, LNBase activity has been previously detected in B. longum strains JCM1217 and JCM7054 (17).
The genomic sequence of B. longum JCM1217 was made publicly available by Fukuda et al. in 2011 (27). Interestingly, we found that this strain possesses no gene homologous to the previously identified LNBase (glycoside hydrolase family 20, GH20) from B. bifidum (17). Although the B. longum JCM1217 genome encodes a GH20 enzyme, the protein obviously lacks the sequence motifs to distinguish LNBase from β-N-acetylhexosaminidase (another GH20 member) (28). Actually, the GH20 enzyme of B. longum JCM1217 was recently found to be β-N-acetylglucosaminidase active on lacto-N-triose II (GlcNAcβ1–3Galβ1–4Glc) and on chitin oligosaccharides but not on LNT (29). These findings prompted us to identify a potentially novel LNBase gene encoded in the genome of B. longum.
Here, we found that the locus tags BLLJ_1505 and BLLJ_1506, neither of which has been functionally annotated, constitute LNBase. The enzyme body is the product of BLLJ_1505, whereas the product of BLLJ_1506 acts as a designated chaperone for the BLLJ_1505 protein (LNBase). The substrate specificity of this novel LNBase was found to be quite different from that of GH20 LNBase. Interestingly, it liberated GalNAcβ1–3GlcNAc from the p-nitrophenyl sugar. The disaccharide structure is present in the O-glycans of α-dystroglycan (30). BLLJ_1505 and BLLJ_1506 homologs were found in the genomes of B. longum, B. bifidum, and a few gut microbes, suggesting that this LNBase has uniquely evolved in particular species.
EXPERIMENTAL PROCEDURES
Chemicals
LNT, lacto-N-neo-tetraose (LNnT, Galβ1–4GlcNAcβ1–3Galβ1–4Glc), LNFP I, LNFP II (Galβ1–3(Fucα1–4)GlcNAcβ1–3Galβ1–4Glc), sialyllacto-N-tetraose (LST)a (Neu5Acα2–3Galβ1–3GlcNAcβ1–3Galβ1–4Glc), and LST b (Galβ1–3(Neu5Acα2–6)GlcNAcβ1–3Galβ1–4Glc) were purchased from IsoSep (Tullinge, Sweden). Lacto-N-hexaose (LNH, Galβ1–3GlcNAcβ1–3(Galβ1–4GlcNAcβ1–6)Galβ1–4Glc) was obtained from Dextra Laboratories (Reading, UK). LNB and lacto-N-triose II (GlcNAcβ1–3Galβ1–4Glc) were prepared as described previously (18, 31). p-Nitrophenyl (pNP)-β-lacto-N-bioside I (LNB-β-pNP) was obtained from Sigma-Aldrich or synthesized essentially as described previously (32). Briefly, hepta-O-acetyl-LNB was prepared by treating LNB with acetic anhydride and pyridine. Following chlorination with hydrogen chloride in acetic acid, p-nitrophenol was glycosylated in dimethylformamide. O-Deacetylation was carried out using sodium methoxide in methanol. The synthesized LNB-β-pNP was used for screening a genomic library of B. longum subsp. longum JCM1217 (described below). GalNAcβ1–3GlcNAcβ-pNP and GalNAcβ1–4GlcNAc (LacdiNAc)β-pNP were purchased from Tokyo Chemical Industry Co. (Tokyo, Japan). Other reagents of analytical grade were obtained from commercial sources. The oligonucleotides used in the plasmid and strain constructions are listed in supplemental Table S1.
Bacterial Strains and Media
The strains used in this study were B. longum subsp. longum JCM1217T and 105-A (33) and Escherichia coli DH5α and BL21 ΔlacZ (DE3)/pRARE2 (23). Bifidobacteria were grown in GAM broth (Nissui Pharmaceutical, Tokyo, Japan) or basal medium (17) at 37 °C under anaerobic conditions. Chloramphenicol and spectinomycin were added at final concentrations of 4 and 30 μg/ml, respectively, as required. E. coli strains were grown in LB broth, and when necessary, ampicillin, chloramphenicol, and spectinomycin were added at concentrations of 100, 30, and 30 μg/ml, respectively.
Construction of a Genomic Library of B. longum JCM1217
The genome of strain JCM1217 was extracted as described previously (13) and partially digested with Sau3AI. The 8–10-kbp DNA fragments were recovered and ligated with the BamHI-digested pBR322. The resulting reaction mixture was used to transform E. coli DH5α to obtain the genomic library, which was then screened for LNB-β-pNP hydrolysis. Note that E. coli DH5α exhibits neither β-1,3-galactosidase nor LNBase activity.
Gene Disruption and Complementation Analysis of B. longum
A targeted gene disruption in B. longum was carried out as follows. The region corresponding to nucleotide numbers 1794468–1795807 (see Fig. 1) was amplified by high fidelity PCR using PrimeStar MAX DNA polymerase (Takara Shuzo, Shiga, Japan). BamHI sites were attached at both ends (supplemental Table S1). The amplified fragment (a partial lnbX gene) was ligated with the 1.9-kbp BamHI fragment (carrying ColE1 ori and the spectinomycin resistance gene) of pBS423 (34) to generate a suicide plasmid. The resulting plasmid was introduced into B. longum 105-A by electroporation and integrated into the genome by a single crossover event at the lnbX locus. Spectinomycin-resistant colonies were isolated, and the disruption of the lnbX gene was confirmed by genomic PCR analysis (data not shown).
FIGURE 1.

Genetic organization of the lnbXY locus in the genome of B. longum subsp. longum JCM1217. Shown is the shortest region contained within the LNBase+-E. coli transformants. The locus tag, the annotated functions, and the Pram motifs are indicated. The numbering is based on GenBankTM accession number NC_015067.
Complementation analysis was performed using E. coli-bifidobacteria shuttle vector pTK2064, in which ColE1 ori (high copy) of plasmid pBS423 (34) was replaced with pSC101 ori (low copy) (supplemental Table S1). Exchanging the ori ensured stable maintenance of the target genes (∼6.3 kbp, GC content 66%) in cells. The lnbX and lnbXY genes (1792583–1798023 and 1792583–1798862 nt, respectively, in Fig. 1) were amplified by high fidelity PCR and inserted into the NdeI site of pTK2064 by the In-Fusion methodology (Clontech) to generate pTK2193 (lnbX+) and pTK2174 (lnbX+Y+), respectively. A plasmid (pTK2241) carrying the lnbY gene under the control of the lnbX promoter was constructed by inverse PCR using pTK2174 as a template, in which nucleotides 1793160–1797962 (Fig. 1) were eliminated (supplemental Table S1). All of the PCR-amplified fragments were sequenced to ensure that no base changes other than those designed had occurred.
Expression and Purification of Recombinant Proteins
Recombinant LnbX and LnbY were expressed in E. coli and purified as both non-tagged and hexahistidine (His)-tagged forms. The expression vectors contained the DNAs coding for amino acid residues 31–1573 of LnbX and amino acid residues 30–280 of LnbY, following genetic removal of the signal peptide and membrane anchor of LnbX and the signal peptide of LnbY. The non-tagged and C-terminal His-tagged LnbX proteins were expressed using pET3a and pET23b (Novagen, Darmstadt, Germany), respectively (supplemental Table S1). The PCR-generated fragments were inserted into the NdeI-BamHI and NdeI-NotI sites of pET3a and pET23b, respectively, by the In-Fusion methodology. To express the non-tagged and N-terminal His-tagged LnbY, the amplified genes were first inserted into the NdeI-BamHI site of pET3a, and the resulting T7 expression cassettes were moved to a ColE1-compatible plasmid pCDF (Novagen) (supplemental Table S1). The entire fragments used for later manipulation were sequenced.
The non-tagged LNBase (LnbX) was purified from the cell-free extract of E. coli cells co-expressing the lnbX and lnbY genes. The cells were grown in 2 liters of LB medium, and when the optical density at 600 nm reached 0.5, isopropyl-β-d-thiogalactopyranoside was added to induce protein expression. The cells were harvested, suspended in 20 mm Tris-HCl buffer (pH 8.0), and disrupted by sonication. The supernatant was applied to a DEAE-Sepharose fast flow column (GE Healthcare), and proteins were eluted by a linear gradient of 1 m NaCl. Each fraction was tested for LNB-β-pNP-hydrolyzing ability. Active fractions were combined, dialyzed to 50 mm sodium phosphate buffer (pH 7.0) containing 0.8 m ammonium sulfate, and applied to a butyl-Sepharose 4 column (GE Healthcare). Elution was performed by decreasing the concentration of ammonium sulfate to 0 m. The protein was further purified by Mono Q 5/50 GL (0–1 m NaCl in 20 mm Tris-HCl buffer (pH 8.0)) (GE Healthcare), Poros HP (0.8–0 m ammonium sulfate in 50 mm sodium phosphate buffer (pH 7.0)) (PerSeptive Biosystems), and Superdex 200 10/300 GL (20 mm Tris-HCl buffer (pH 8.0) containing 150 mm NaCl) (GE Healthcare) column chromatography. The purified protein was concentrated using an Amicon Ultra 100K concentrator (Millipore, MA). His-tagged LnbX was similarly expressed and purified by nickel-nitrilotriacetic acid-agarose (Qiagen, Hilden, Germany), Mono Q 5/50 GL, and Superdex 200 10/300 GL column chromatography.
Non-tagged LnbY was purified similarly, using the same columns. The purity of LnbY was assessed by SDS-polyacrylamide gel electrophoresis of each fraction. His-tagged LnbY was purified by nickel-nitrilotriacetic acid-agarose and Superdex 75 10/300 GL column chromatography. The purified protein was concentrated using an Amicon Ultra 10K concentrator.
Protein concentrations were determined using a Bradford protein assay kit (Bio-Rad). Bovine serum albumin was used as a standard.
Inductively Coupled Plasma Emission Spectroscopy
Prior to the analysis, the purified, non-tagged LnbX and LnbY were extensively dialyzed against 5 mm Tris-HCl (pH 8.0) in the presence and absence of 0.2 mm EDTA. The content and concentration of metal ions in the proteins were determined by inductively coupled plasma emission spectroscopy using ICPS-8100 (Shimadzu, Kyoto, Japan), with dialysis buffer as a control. The standard was ICP multielement standard solution IV.
Edman Degradation Analysis
The N-terminal amino acid sequence of the non-tagged LnbX was determined by Edman degradation using a PPSQ-33A protein sequencer (Shimadzu).
Enzyme Assay
The standard reaction mixture contained 50 mm MES buffer (pH 5.4). pNP-sugars and oligosaccharides were used as the substrates. The reaction was initiated by adding the enzyme, and the reaction mixture was incubated at 25 °C for an appropriate time, in which the linearity of the reaction rate was observed. The enzyme concentrations used in the kinetic analysis were 0.90 nm (LNB-β-pNP), 1.8 nm (GalNAcβ1–3GlcNAcβ-pNP and LNT), and 140 nm (LNFP I). The substrate concentrations were varied from 0.3 to 2 times the respective Km values. The reaction was terminated by adding 1 m sodium carbonate (for pNP-sugars) or by heating (for oligosaccharides). The amount of liberated p-nitrophenol was determined from the absorbance at 400 nm. Oligosaccharide hydrolysis was monitored by high performance anion exchange chromatography with pulsed amperometric detection (HPAEC-PAD) using a Dionex ICS 3000 system, equipped with a CarboPac PA-1 column (Dionex, Sunnyvale, CA). The elution was performed under constant flow (0.25 ml/min) with a linear gradient of 0-330 mm sodium acetate in 125 mm NaOH at 30 °C for 20 min. Standard curve was constructed from known concentrations of Lac. The reaction products of the LNFP I hydrolysis were treated with 1,2-α-l-fucosidase (13) prior to HPAEC-PAD analysis to remove the fucosyl residue from the 2′-fucosyl-LNB (Fucα1–2Galβ1–3GlcNAc) (reaction product), which co-elutes with Lac. The kinetic parameters were calculated by curve-fitting the experimental data to the Michaelis-Menten equation, using KaleidaGraph version 4.0 (Synergy Software). One unit of enzyme activity was determined as the amount of enzyme required to produce 1 μmol of p-nitrophenol or Lac under the specified conditions.
The physicochemical properties of the enzyme were determined using 1 mm LNB-β-pNP as a substrate. To estimate the optimal temperature, the reaction mixture was incubated at various temperatures for a short period (<1 min). The optimal pH was determined using the following buffers (100 mm): citrate-NaOH (pH 4.0–5.0), MES (pH 5.0–6.5), MOPS (pH 6.5–8.0), and Tris-HCl (pH 8.0–9.0). The temperature and pH stabilities were determined from the residual activities following enzyme incubation in 50 mm MES (pH 5.4) for 30 min at various temperatures and overnight dialysis against various 10 mm buffers at 4 °C, respectively.
The native molecular mass of the proteins was determined by size exclusion chromatography using Superdex 200 10/300 GL (for LnbX) and Superdex 75 10/300 GL (for LnbY). Thyroglobulin (669 kDa), ferritin (440 kDa), aldolase (158 kDa), conalbumin (75 kDa), ovalbumin (43 kDa), ribonuclease A (13.7 kDa), and aprotinin (6.5 kDa) were used as standards. Void volume was determined by blue dextran 2000.
Determination of Stereochemical Course of Hydrolysis
The reaction mixture containing 50 mm MES buffer (pH 5.4), 2 mm LNB-β-pNP, and the enzyme (7 milliunits) was incubated at 30 °C in a total volume of 60 μl. The mixture was sampled at specified times and immediately injected into a high performance liquid chromatography (HPLC) system equipped with TSKgel Amide-80 (4.6 × 250 mm) (Tosoh, Tokyo, Japan). Elution was carried out using a solvent system of acetonitrile/water of 65:35 at a flow rate of 1 ml/min and was monitored at 214 nm.
Electrospray Ionization-MS
For oligosaccharide analysis, mass spectra were obtained on an LCMS-2020 system (Shimadzu) in positive ion mode. The samples were dissolved in 0.1% formic acid/acetonitrile (1:1 by volume) and injected at 3 μl/min with a microsyringe pump.
Western Blot Analysis Using Anti-His Tag Antibodies
Cell-free extracts (0.6 mg) of E. coli cells expressing His-tagged LnbX in the presence and absence of co-expression of non-tagged LnbY were separated by size exclusion chromatography (Superdex 200 10/300 GL). Each fraction (0.5 ml) was assayed for protein concentration, LNBase activity, and LnbX content. LnbX was detected using anti-His-tag antibodies conjugated with horseradish peroxidase (Qiagen), following SDS-polyacrylamide gel electrophoresis and membrane transfer (Immobilon-P, Millipore). Chemiluminescence was detected using ECL Western blotting detection reagents (GE Healthcare Life Sciences) and a LAS-3000 imaging system (Fujifilm, Tokyo, Japan).
In Vitro Refolding of LnbX
Denatured LnbX was refolded in the presence and absence of LnbY and metals (Ca2+ and Mg2+). This experiment was carried out on C-terminal His-tagged LnbX and N-terminal His-tagged LnbY. The purified LnbX (final concentration 1 μm) denatured in 6 m guanidine HCl was diluted 100-fold by adding 50 mm HEPES buffer (pH 7.0) containing various concentrations of LnbY (0, 1, 5, 20, and 50 μm) and metal ions (0, 0.01, 0.1, 1, and 5 mm CaCl2 and MgCl2) in a total volume of 500 μl. The mixture was immediately placed in the dialysis cassette (Slide-A-Lyzer G2, Thermo Scientific, MA), and dialyzed against HEPES buffer containing or not containing metal ions. The samples were removed from the dialysis cassettes at specified times and monitored for hydrolytic activity toward LNB-β-pNP. Enzymes were assayed within 2 min of incubation to avoid refolding during activity determination.
RESULTS
Identification of BLLJ_1505 and BLLJ_1506 as the Constituents of LNBase from B. longum
A genomic library of B. longum JCM1217 was constructed using E. coli DH5α, and the transformants were screened for their ability to liberate p-nitrophenol from LNB-β-pNP. Five of 1920 transformants tested positive for the activity. Sequence analysis revealed that the DNA fragment in the plasmid isolated from the clones covers a particular genomic locus. The shortest fragment comprises genomic nucleotides 1792199–1800198 (Fig. 1). This region includes two complete open reading frames (ORFs) designated BLLJ_1505 (1599 aa) and BLLJ_1506 (280 aa). Neither ORF had been functionally annotated; nor did they share sequence similarities with any characterized proteins. The insert also contained two truncated ORFs (BLLJ_1504 and BLLJ_1507), which were close homologs of bacterial γ-glutamylcysteine synthetase and 2-hydroxyglutaryl-CoA dehydratase activator, respectively. Pfam analysis indicated a right-handed β helix region (β helix, PF13229) at amino acid residues 158–315 of BLLJ_1505 and an uncharacterized sugar-binding domain (FIVAR, PF07554) at residues 1435–1487, whereas BLLJ_1506 lacks any functional motifs (35). The SignalP 4.1 and PSORT servers predicted the presence of a signal peptide (1–30 aa) and a membrane anchor (1577–1593 aa) in BLLJ_1505 and a signal peptide (1–29 aa) in BLLJ_1506 (36). BLLJ_1505 and BLLJ_1506 were separated by 3 bp, and an inverted repeat was found immediately downstream of BLLJ_1506 (1798848–1798889 nt). Homologs of these proteins in the database are introduced below.
We first disrupted locus tag BLLJ_1505 by a homologous recombination event. This manipulation was performed on B. longum strain 105-A (LNBase+) rather than JCM1217, because the latter is not amenable to standard genetic manipulation (33). Sequence identity of 99% was observed between the genes from both strains (data not shown). Disruption of the corresponding gene in strain 105-A resulted in complete loss of LNT-hydrolyzing ability, as revealed by TLC analysis (Fig. 2, lane 3). Activity was not restored by introducing BLLJ_1505 via a shuttle vector (Fig. 2, lane 5). BLLJ_1506 alone similarly failed to rescue the LNBase− phenotype (Fig. 2, lane 6); however, when both BLLJ_1505 and BLLJ_1506 were introduced, the activity resumed (Fig. 2, lane 7). These results indicate that LNBase of B. longum JCM1217 consists of BLLJ_1505 and BLLJ_1506 (hereafter referred to as lnbX and lnbY, respectively).
FIGURE 2.
Complementation analysis of lnbX-deficient B. longum subsp. longum. The strain carrying a disrupted lnbX gene was transformed with a plasmid carrying lnbX, lnbY, or lnbXY. Note that lnbY was expressed under the control of the lnbX promoter. The cells were grown in GAM medium overnight, harvested, and then suspended in basal medium (17) containing 5 mm LNT. The suspensions were incubated anaerobically for 1 h, and the supernatants were analyzed by thin layer chromatography using a solvent system of 1-butanol/acetic acid/water (2:1:1 by volume). The sugars were visualized by diphenylamine-phosphoric acid (45). Lane 1, JCM1217; lane 2, 105-A; lane 3, 105-A lnbX::SpR; lane 4, pTK2064 (empty vector)/lnbX::SpR; lane 5, pTK2064-lnbX+/lnbX::SpR; lane 6, pTK2064-lnbY+(lnbXp)/lnbX::SpR; lane 7, pTK2064-lnbX+Y+/lnbX::SpR. Standards used were LNT, Lac, and LNB.
Besides B. longum, both lnbX and lnbY were required for the active LNBase expression in E. coli. In this experiment, the signal peptide and membrane anchor of LnbX and the signal peptide of LnbY were genetically removed, and the corresponding genes were expressed in separate plasmids (see “Experimental Procedures”). The cell-free extract of the E. coli strain carrying both lnbX and lnbY showed LNB-β-pNP-hydrolyzing activity (9.5 units/mg), whereas strains expressing either lnbX or lnbY did not (Table 1). Interestingly, mixing the cell-free extracts of E. coli strains individually expressing lnbX and lnbY induced low level activity (0.38 unit/mg). When added prior to mixing, EDTA completely quenched the activity, whereas after mixing, it produced no effect on activity (0.34 unit/mg). Similarly, EDTA did not alter the activity in the cell-free extract of E. coli cells co-expressing lnbX and lnbY (9.5 versus 9.6 units/mg).
TABLE 1.
LNBase activity of LnbX-, LnbY-, and LnbXY-expressing E. coli cells
The reaction was carried out in 50 mm MES buffer (pH 5.4) containing 1 mm LNB-β-pNP at 30 °C. EDTA (final concentration 1 mm) was added where indicated.
| Cell-free extracts of E. coli cells expressing | Specific activity |
|---|---|
| units/mg | |
| LnbX | NDa |
| LnbY | ND |
| LnbXY | 9.5 |
| LnbXY + EDTA | 9.6 |
| LnbX + LnbYb | 0.38 |
| LnbX + LnbY + EDTA | |
| LnbX + LnbY before mixingc | ND |
| LnbX + LnbY after mixingd | 0.34 |
a ND, not detected.
b Prior to the enzyme assay, the cell-free extracts of E. coli cells individually expressing LnbX and LnbY were mixed and incubated for 30 min at 30 °C.
c EDTA was added before mixing.
d EDTA was added after mixing.
Purification and Physicochemical Characterization
We first purified non-tagged recombinant LNBase from E. coli cells co-expressing LnbX and LnbY. Purification was carried out by monitoring the LNB-β-pNP-hydrolyzing activity. The purification process is summarized in Table 2. The purified protein yielded a single band on SDS-polyacrylamide gel electrophoresis with an apparent molecular mass of 161 kDa, which agrees with the calculated mass of LnbX (164 kDa) (Fig. 3a). Edman degradation analysis revealed the N-terminal amino acid sequence as MQSAT, consistent with the designed construct for expressing LnbX (31–1573 residues). The addition of His tag to the C terminus of the protein did not alter the enzymatic properties of LnbX (discussed below), and the tagged protein was easily purified by Ni2+ affinity chromatography. Moreover, LnbX migrated to a virtually identical position in the SDS-polyacrylamide gel electrophoresis regardless of whether LnbY was co-expressed or not (see Fig. 7a). The addition of purified LnbY to purified LnbX (correctly folded form, described below) produced no effect on LNBase activity (data not shown). These results indicated that the active LNBase molecule from B. longum is a single gene product (that of lnbX). The native molecular mass of LNBase (LnbX) deduced from size exclusion chromatography was 356 kDa, indicating that the enzyme forms a dimer in solution (Fig. 3b).
TABLE 2.
Summary of purification of recombinant non-tagged LNBase (LnbX)
| Purification stepa | Total protein | Total units | Specific activity | -Fold | Yield |
|---|---|---|---|---|---|
| mg | units | units/mg | -fold | % | |
| Cell-free extract | 591 | 6020 | 10.2 | 1 | 100 |
| DEAE-Sepharose fast flow | 262 | 5120 | 19.5 | 1.9 | 85 |
| Butyl-Sepharose 4 | 113 | 3410 | 30.2 | 3.0 | 57 |
| Mono Q 5/50 GL | 61.8 | 2150 | 34.8 | 3.4 | 36 |
| Poros HP 4.6/100 | 30.9 | 1130 | 36.6 | 3.6 | 19 |
| Superdex 200 10/300 GL | 18.0 | 670 | 37.2 | 3.6 | 11 |
a LNBase was purified from the cell-free extracts of E. coli cells co-expressing non-tagged LnbX and LnbY proteins. Purification was carried out by monitoring LNB-β-pNP-hydrolyzing activity, as described under “Experimental Procedures.” See also Fig. 3.
FIGURE 3.

Purification of non-tagged, recombinant LnbX and LnbY proteins. a, the results of SDS-polyacrylamide gel electrophoresis. LNBase (LnbX) was purified by monitoring LNB-β-pNP-hydrolyzing activity. The N-terminal five amino acid residues of LnbX are MQSAT, determined by Edman degradation. The purified proteins were examined for their metal content (see “Results”). b, the native molecular weights of LnbX and LnbY were determined by size exclusion chromatography using Superdex 200 10/300 GL (for LnbX) and Superdex 75 10/300 GL (for LnbY) columns. Thyroglobulin (669 kDa), ferritin (440 kDa), aldolase (158 kDa), conalbumin (75 kDa), ovalbumin (43 kDa), ribonuclease A (13.7 kDa), and aprotinin (6.5 kDa) were used as standards.
FIGURE 7.
Requirement of LnbY for proper folding of LnbX. a, the results of SDS-polyacrylamide gel electrophoresis of the soluble fraction of the cell-free extracts of E. coli cells expressing either LnbX(His) alone or LnbX(His) and LnbY. b, the cell-free extracts were separated by size exclusion chromatography (Superdex 200 10/300 GL). Each fraction (0.5 ml) of the elution volume (7.5–13 ml) was subjected to SDS-polyacrylamide gel electrophoresis, followed by Western blot analysis using anti-His tag antibodies linked to horseradish peroxidase. The fractions were also assayed for protein (mg/ml) and enzyme activity (units/mg). The peak fractions of the marker proteins (thyroglobulin, 669 kDa; ferritin, 440 kDa; aldolase, 158 kDa) and the void fraction are indicated. c, in vitro refolding of denatured LnbX (1 μm) was carried out in the presence and absence of LnbY (1 μm) and the metal ions (0.1 mm CaCl2 and MgCl2). The refolding mixture comprising denatured LnbX alone (open circles); denatured LnbX and metal ions (filled circles); denatured LnbX and non-denatured LnbY (open squares); or denatured LnbX, non-denatured LnbY, and metal ions (filled squares) was dialyzed against 50 mm HEPES buffer containing or not containing 0.1 mm metal ions. The samples were removed from the dialysis cassettes at the indicated times and assayed for activity content. d, the refolding was carried out in varying concentrations of LnbY in the presence of 0.1 mm metal ions. The ratios of LnbY to denatured LnbX are 0 (filled circles), 1 (filled squares), 5 (open diamonds), 20 (open triangles), and 50 (filled triangles).
Inductively coupled plasma emission spectroscopy revealed that LnbX contains 1 ± 0.1 molecule of magnesium, 3 ± 0.6 molecules of calcium, and 0.4 ± 0.1 molecule of zinc. Magnesium and calcium ions are probably tightly bound to or buried in the protein because the addition of EDTA to the dialysis buffer did not alter the metal contents; however, zinc ion was removed from the protein by adding EDTA. Recall that EDTA does not affect the specific activity of the purified enzyme.
The optimal pH and temperature of the enzyme for LNB-β-pNP hydrolysis was 5.4 (MES buffer) and 60 °C, respectively. The enzyme was stable in the pH range 4.5–9.5 and below 45 °C for 30 min. The purified recombinant enzyme maintained its activity for at least 3 weeks (data not shown).
We also purified non-tagged LnbY (Fig. 3a). The molecular mass of recombinant LnbY (30–280 aa) was estimated to be 28.2 kDa (calculated, 27.4 kDa) on SDS-polyacrylamide gel electrophoresis and 48.5 kDa on gel filtration analysis, indicating a dimer formation (Fig. 3b). LnbY appeared to contain no metal ions.
Substrate Specificity
Substrate specificity was determined using C-terminal His-tagged LnbX. The specific activity on LNB-β-pNP was essentially the same for the His-tagged (34.1 units/mg) and non-tagged (37.2 units/mg) enzymes. Hydrolytic activity was evaluated by overnight incubation of the enzyme (6 milliunits toward LNB-β-pNP) with various pNP-sugars (1 mm) and oligosaccharides (5 mm) (Table 3 and Fig. 4). The activity of GH20 LNBase from B. bifidum (LnbB) was also evaluated for comparison (17, 28). LnbX hydrolyzed both LNB-β-pNP and GalNAcβ1–3GlcNAcβ-pNP, whereas LnbB was inactive toward GalNAcβ1–3GlcNAcβ-pNP (Table 3). LnbX was able to act on LNT, LNH, LNFP I, and LST a, whereas LnbB acted only on LNT and LNH (Fig. 4, a, d, e, and g). The hydrolysis of LNT, LNFP I, and LST a by LnbX at the Galβ1–3GlcNAc linkage was confirmed by electrospray ionization-MS analysis. The reaction products of LNT hydrolysis yielded molecular ion peaks corresponding to sodium adducts of Lac (calculated for [M + Na]+, 365.11; observed, 365.05) and LNB (calculated for [M + Na]+, 406.13; observed, 406.05) (Fig. 5a), whereas the LNFP I hydrolysis gave rise to sodium adducts of Lac (observed, 365.05) and 2′-fucosyl-LNB (calculated for [M + Na]+, 552.19; observed, 552.20) (Fig. 5b). The spot corresponding to a trisaccharide in the TLC analysis of the LST a hydrolysate yielded molecular ion peaks matching sodium adduct (calculated for [M + Na]+, 697.23; observed, 697.20) and deprotonated, disodium adduct (calculated for [M − H + 2Na]+, 719.21; observed, 719.15) of 3′-sialyl-LNB (Fig. 5c). No corresponding peaks appeared in the control experiments without enzyme (data not shown).
TABLE 3.
Substrate specificity of LNBases from B. longum subsp. longum (LnbX) and B. bifidum (LnbB)
| Substrate | Hydrolysisa |
Kinetic parameter |
||||||
|---|---|---|---|---|---|---|---|---|
| LnbX |
LnbBb |
|||||||
| LnbX | LnbB | Km | kcat | kcat/Km | Km | kcat | kcat/Km | |
| mm | s−1 | mm−1s−1 | mm | s−1 | mm−1s−1 | |||
| LNB-β-pNP | ||||||||
| Galβ1–3GlcNAcβ-pNP | +++ | +++ | 0.119 ± 0.022 | 96.1 ± 4.1 | 806 ± 123 | 0.099 ± 0.011 | 15.4 ± 0.7 | 156 ± 11 |
| GalNAcGlcNAc-β-pNP | ||||||||
| GalNAcβ1–3GlcNAcβ-pNP | +++ | − | 0.186 ± 0.010 | 39.4 ± 0.6 | 211 ± 8 | |||
| Lacto-N-tetraose | ||||||||
| Galβ1–3GlcNAcβ1–3Galβ1–4Glc | +++ | +++ | 0.401 ± 0.015 | 113 ± 2 | 282 ± 7 | 0.626 ± 0.029 | 42.1 ± 0.9 | 67.2 ± 1.9 |
| Lacto-N-neotetraose | ||||||||
| Galβ1–4GlcNAcβ1–3Galβ1–4Glc | − | − | ||||||
| Lacto-N-triose II | ||||||||
| GlcNAcβ1–3Galβ1–4Glc | − | − | ||||||
| Lacto-N-hexaose | ||||||||
| Galβ1–3GlcNAcβ1–3(Galβ1–4GlcNAcβ1–6)Galβ1–4Glc | ++ | ++ | NDc | ND | ND | ND | ND | ND |
| Lacto-N-fucopentaose I | ||||||||
| Fucα1–2Galβ1–3GlcNAcβ1–3Galβ1–4Glc | +++ | − | 14.6 ± 4.3 | 13.5 ± 1.5 | 0.923 ± 0.179 | |||
| Lacto-N-fucopentaose II | ||||||||
| Galβ1–3(Fucα1–4)GlcNAcβ1–3Galβ1–4Glc | − | − | ||||||
| Sialyllacto-N-tetraose a | ||||||||
| Neu5Acα2–3Galβ1–3GlcNAcβ1–3Galβ1–4Glc | + | − | ND | ND | ND | |||
| Sialyllacto-N-tetraose b | ||||||||
| Galβ1–3(Neu5Acα2–6)GlcNAcβ1–3Galβ1–4Glc | − | − | ||||||
a The reactions were carried out in 50 mm MES buffer (pH 5.4) (for LnbX) and citrate-phosphate buffer (pH 4.5) (for LnbB) containing 1 mm (for pNP-sugars) and 5 mm (for oligosaccharides) substrates. Mixtures were incubated overnight at 25 °C in the presence and absence of the enzyme (6 milliunits toward pNP-LNB). The reaction products were analyzed by thin layer chromatography (see Fig. 4). Neither LnbX nor LnbB acted on pNP-monosaccharides (l-Arapα-pNP, Galβ-, GalNAcβ-, Glcβ-, GlcNAβ-, GlcUAβ-, Manβ-, Xylβ-), Lacβ-pNP, and LacdiNAcβ-pNP. +++, complete hydrolysis (100%); ++, significant hydrolysis (>50%); +, partial hydrolysis (<50%); −, no hydrolysis.
b The kinetic parameters of LnbB are taken from our recent report (28).
c ND, not determined.
FIGURE 4.
Substrate specificity of LNBases from B. longum subsp. longum (LnbX) and from B. bifidum (LnbB, a GH20 enzyme). The reactions were carried out in 50 mm MES (pH 5.4) (for LnbX) and citrate-phosphate (pH 4.5) (for LnbB) buffers containing 5 mm substrates in the presence and absence of the enzyme (6 milliunits toward LNB-β-pNP). The reaction products were analyzed by thin layer chromatography using a solvent system of 1-butanol/acetic acid/water (2:1:1 by volume). The sugars were visualized by diphenylamine-phosphoric acid (45). The substrates used were LNT (a), LNnT (b), lacto-N-triose II (LNTri II) (c), LNH (d), LNFP I (e), LNFP II (f), LST a (g), and LST b (h). *1 and *2 indicate 3′-sialyl-lacto-N-biose I (hydrolysis product, see Fig. 5c) and LNT (contaminant of LST b), respectively. Standards (Std.) used are lactose and each substrate (far left lane) and lacto-N-biose I (near left lane). See also Table 3.
FIGURE 5.
Electrospray ionization-MS analysis of the reaction products catalyzed by LnbX. The reactions were carried out in 50 mm MES (pH 5.4) buffer containing 5 mm LNT (a), LNFP I (b), and LST a (c) in the presence of the enzyme. When LNT and LNFP I were used as substrates, the reaction products were deionized by Amberlite MB-3 (Millipore) and lyophilized prior to the analysis. In LST a hydrolysis, the reaction products were first separated by thin layer chromatography, and the spot corresponding to a trisaccharide was extracted and purified by Sep-Pak C18 Plus (Waters, MA). Control experiments were performed without the enzyme (data not shown).
Both LnbX and LnbB were inactive on LNnT, lacto-N-triose II, LNFP II, and LST b (Fig. 4, b, c, f, and h). Neither enzyme hydrolyzed pNP-monosaccharides (l-Arapα-pNP, Galβ-pNP, GalNAcβ-pNP, Glcβ-pNP, GlcNAβ-pNP, GlcUAβ-pNP, Manβ-pNP, Xylβ-pNP), Lacβ-pNP, or GalNAcβ1–4GlcNAc (LacdiNAc)β-pNP.
The activity of LnbX toward LNB-β-pNP (1 mm) was not inhibited by LacNAc (5 mm). The rate of hydrolysis of GalNAcβ1–3GlcNAcβ-pNP (1 mm) by LnbX was not affected in the presence of 5 mm LacdiNAcβ-pNP (data not shown).
Kinetic analysis revealed that the catalytic efficiency of LnbX toward LNB-β-pNP and LNT is 5- and 4-fold higher, respectively, than that of LnbB (806 versus 156 mm−1 s−1 for LNB-β-pNP; 282 versus 67.2 mm−1 s−1 for LNT) (Table 3). This difference is mostly due to the higher kcat values of LnbX (96.1 s−1 for LNB-β-pNP and 113 s−1 for LNT) than those of LnbB (15.4 s−1 for LNB-β-pNP and 42.1 s−1 for LNT) toward these substrates. The kinetic analysis also revealed that activity of LnbX on GalNAcβ1–3GlcNAcβ-pNP (kcat/Km value of 211 mm−1 s−1) is significant and comparable with that on LNB-β-pNP. Relative to LNT, LnbX showed 40-fold higher Km value (14.6 versus 0.401 mm) and 8-fold lower kcat value (13.5 versus 113 s−1) for LNFP I, implying that the enzyme is less effective toward LNFP I (nonetheless significant; see Fig. 4e). The activity of the enzyme on LST a was too low to determine the kinetic parameters.
Stereochemistry of Hydrolysis
Stereochemical course of the reaction was determined by monitoring the anomeric configuration of LNB released from the pNP-substrate (Fig. 6). A normal phase HPLC was employed for this purpose. LNB appeared with a ratio of α-anomer to β-anomer of 25:75 and 35:65 after 1- and 10-min incubation, respectively. The peak area for LNB-β-pNP decreased, whereas those of p-nitrophenol and LNB increased as the reaction proceeded (10 and 30 min), and the α/β-ratio of LNB had almost reached the equilibration of mutarotation (60/40) at 120 min. These results showed that LnbX is a retaining enzyme.
FIGURE 6.

Stereochemical course of the hydrolysis catalyzed by LnbX. The reaction mixture containing 50 mm MES buffer (pH 5.4), 2 mm LNB-β-pNP, and the enzyme (7 milliunits) was incubated at 30 °C and sampled at the indicated times to be analyzed by an HPLC system equipped with TSKgel Amide-80 (4.6 × 250 mm). Elution was carried out at room temperature using acetonitrile/water (65:35) flowing at 1 ml/min and was monitored by measuring the absorbance at 214 nm.
Role of LnbY in the Folding Process of LnbX
To examine the folding state of LnbX, we performed gel filtration analysis using the cell-free extracts of E. coli cells expressing His-tagged LnbX with and without LnbY (non-tagged), followed by SDS-polyacrylamide gel electrophoresis and Western blot analysis using anti-His tag antibodies (Fig. 7, a and b). The protein concentration and specific activity (from 7.5- to 13-ml elution volume) were also determined for each fraction. The quantity of His-tagged LnbX obtained in a soluble fraction was consistent and independent of LnbY co-expression (Fig. 7a). LnbX eluted in a void volume in the absence of LnbY, whereas it eluted at 10.5–11.0 ml (molecular mass 399–316 kDa) in the presence of LnbY. No LNBase activity was detected in any fractions of cell-free extract of the strain expressing LnbX alone, whereas the activity exactly coincided with the LnbX protein peak of the cell-free extract of the strain co-expressing LnbY in the chromatography.
In vitro refolding experiment of LnbX was also performed, in which the renaturation process was represented by the enzymatic activity on LNB-β-pNP (see “Experimental Procedures”). When the denatured LnbX was incubated and dialyzed alone, no detectable activity was observed throughout the incubation periods (Fig. 7c). No precipitation occurred during dialysis to reflect that the protein formed a soluble aggregate in the cell-free extracts of E. coli cells expressing LnbX alone (Fig. 7b, left). In contrast, when the refolding solution contained LnbY (non-denatured), activity gradually recovered. Efficient refolding occurred when Ca2+ and Mg2+ were supplemented together with LnbY. As mentioned above, both metal ions are contained in the native enzyme. Magnesium ions were found to be more important than calcium ions in the refolding process. When Mg2+ alone was added, the activity was over 90% of that obtained in the presence of the two metal ions, whereas Ca2+ alone failed to attain 70% activity (data not shown). Refolding also depended on the concentration of the metal ions; 0.1 mm was found to optimize refolding within the tested range (10 μm, 0.1 mm, 1 mm, and 5 mm; data not shown). Interestingly, the metal ions by themselves could slightly stimulate the refolding of denatured LnbX, and very low but non-negligible activity was detected as the incubation continued (Fig. 7c). Refolding efficiency varied with the molar ratio of LnbY added to denatured LnbX. When the ratios were increased to 5 and 20 from equimolar, LNB-β-pNP-hydrolyzing activity was elevated by 1.2- and 1.5-fold, respectively; however, a ratio of 50 caused a decline in the activity (Fig. 7d). The highest activity attained in the refolding experiments (6.3 units/mg) was one-sixth that of the native recombinant enzyme (37.2 units/mg), indicating a renaturation efficiency of about 17%.
DISCUSSION
The present study revealed a novel LNBase in B. longum that completely differs from hitherto identified GH families with respect to amino acid sequence, substrate specificity, maturation process, and possibly structure.
Physicochemical Properties
Initially, we considered that LNBase is a heterodimer comprising the LnbX and LnbY subunits because LNB-β-pNP-hydrolyzing activity occurred when the cell-free extracts of E. coli strains individually expressing LnbX and LnbY were mixed and incubated (Table 1). However, the subsequent experiments revealed that the purified LNBase consists solely of the lnbX gene product. The C terminus of the protein could be truncated to 1431 amino acid residues (immediately upstream of the FIVAR domain; Fig. 1) without loss of activity (data not shown).
Sequence Features
In the complementation analysis using lnbX-deficient B. longum, plasmid-mediated introduction of the lnbX gene failed to restore LNBase activity, although the genome of the deficient strain contained an intact lnbY. Introduction of both lnbX and lnbY genes by plasmid recovered the LNBase+ phenotype of the parental strain (Fig. 2). These results indicate that the lnbX and lnbY genes constitute an operon, and the failure of the phenotypic change in the strain carrying plasmid-borne lnbX is due to a polar effect. The two genes were separated by a mere 3 bp, and a promoter-like sequence was not found upstream of the ORF of lnbY; instead, a 42-bp inverted repeat was found immediately downstream of lnbY.
In the genomes of B. longum JCM1217 and B. longum BBMN68, the lnbXY gene is located between the γ-glutamylcysteine synthetase and 2-hydroxyglutaryl-CoA dehydratase activator genes (99% identity in nucleotide sequence over the region covering the four genes) (supplemental Fig. S2). In the genomes of B. longum strains DJ010A, F8, JDM301, KACC91563, and NCC2705 (possibly LNBase−), the γ-glutamylcysteine synthetase gene is located just downstream of the 2-hydroxyglutaryl-CoA dehydratase activator gene (KEGG database). We currently lack knowledge of how strains JCM1217 and BBMN68 acquired the lnbXY gene at this locus. No insertion sequence was found at either end of the gene (IS Finder). Interestingly, however, the genomes of B. bifidum strains BGN4, PRL2010, and S17 contain lnbX and lnbY homologs with 50–60% amino acid sequence identity, which are also located near the γ-glutamylcysteine synthetase and 2-hydroxyglutaryl-CoA dehydratase activator genes (supplemental Fig. S2). In these genomes, the lnbX and lnbY homologs are separated by the γ-glutamylcysteine synthetase gene, and their sense strands are opposed. Note that in B. bifidum, either the LnbX homolog or the LnbY homolog lacks a signal peptide; therefore, although both proteins are expressed in the cells, they cannot associate to assist the folding of LnbX.
The LnbX homologs have been found in the human gut microbial genomes of Ruminococcus lactaris ATCC29176 (RUMLAC_00599), Clostridium nexile DSM1787 (clonex_02958), and Clostridium celatum DSM1785 (HMPRF0216_02974). The amino acid identity between these homologs and B. longum LnbX is about 40%. Among these bacteria, R. lactaris ATCC29176 alone possesses the LnbY homolog (27% identity, RUMLAC_00598), but the protein lacks a signal peptide. These results suggest that the gene(s) has specifically evolved within the gut niche. Given the length and sequence diversity among the few known occurrences, the gene(s) might still be evolving. Further elucidation requires characterization of each of these homologs.
Substrate Specificity
Besides sequence, the substrate specificity of LNBase from B. longum significantly differs from that of GH20 LNBase from B. bifidum. Whereas GH20 LNBase (including one from Streptomyces sp.) acts only on unmodified LNB structures (Fig. 4) (17, 37), the novel LNBase from B. longum was able to act on LNFP I and LST a, which have Fuc and Neu5Ac residues at the O2 and O3 positions of the distal Gal residue, respectively. Considering the high activity of LnbX on LNT, followed by LNFP I and LST a, and that the enzyme is inactive on GlcNAc-pNP, binding of the substrate at subsite −2 might be indispensable for the enzyme to exert its activity. The subsite −2 is slightly widened at the O2 position of −2 Gal, enabling LnbX to efficiently hydrolyze GalNAcβ1–3GlcNAcβ-pNP (Table 3). GalNAcβ1–3GlcNAcβ disaccharide structure has been found in the O-mannosyl glycans of α-dystroglycan, and β1–3GalNAc transferase with acceptor specificity toward GlcNAc (B3GALNT2) has been identified in humans and mice (38). Recently, Stevens et al. (39) reported that mutations in B3GALNT2 cause congenital muscular dystrophy-dystroglycanopathy, characterized by brain and eye anomalies. GalNAcβ1–3GlcNAc is a linkage isomer of LacdiNAc (N,N′-diacetyllactosediamine, GalNAcβ1–4GlcNAc) found in the N-glycans of glycoproteins such as lutropin (a hormone produced by gonadotroph cells) and tenascin-R (an extracellular matrix exclusively expressed in the central nervous system) as well as in glycoproteins from parasites (40, 41). The LacdiNAc structure in the leukemia inhibitory factor receptor is known to influence self-renewal maintenance of mouse embryonic stem cells (42). Considering that LnbX does not act on LacdiNAcβ-pNP and that GalNAcβ1–3GlcNAcβ-pNP hydrolysis is not inhibited by the presence of LacdiNAcβ-pNP, the enzyme may serve as a new tool for examining the glycan structures of glycoconjugates and for distinguishing between GalNAcβ1–3GlcNAc and LacdiNAc structures. However, we have not tested whether the enzyme can liberate GalNAcβ1–3GlcNAc from natural substrates.
With respect to the unique substrate specificity of B. longum LNBase, we also emphasize that B. longum JCM1217 grown in HMO medium induces a slight but continuous decrease of LNFP I (from 0.67 to 0.24 g/liter) (12). We did not identify 2′-fucosyl LNB in that study because we lacked a standard compound, and we had not elucidated the unique substrate specificity of LnbX. Interestingly, the HPLC profile in that paper displays a small peak between Lac and 2′-fucosyllactose (12).
LnbY as a Designated Chaperone for LnbX
In both bifidobacteria and E. coli, LnbY is required for active expression of LnbX (i.e. LNBase activity (Table 1 and Fig. 2)). In the absence of LnbY co-expression, LnbX formed a soluble aggregate and eluted in the void fraction in the gel filtration analysis with no detectable activity (Fig. 7b, left). In the presence of LnbY, active LnbX was expressed and eluted at the anticipated fraction (Fig. 7b, right). Also, as mentioned above, no apparent post-translational modification occurred on LnbX. These results strongly suggest that the LnbY protein is involved in the folding process of LnbX. The denatured LnbX gained considerable activity during the incubation with LnbY and removal of guanidine HCl by dialysis (Fig. 7c). The presence of two metal ions (Ca2+ and Mg2+, especially Mg2+) was important for efficient refolding (Fig. 7c). The addition of EDTA to mature LnbX had no effect on enzymatic activity (Table 1) and did not sequester the ions during dialysis, indicating that the two metal ions were tightly bound by the protein and stabilized the correct folding of LnbX. Indeed, the two metals slightly stimulated correct folding of LnbX even in the absence of LnbY (Fig. 7c). The results in Table 1 also indicate that LnbY can partially renature a soluble aggregate form of LnbX. To our knowledge, this is the first glycosidase that requires a designated chaperone for its active expression. Mucin type core 1 (T antigen)-synthesizing β1–3Gal transferase (C1βGal-T) is known to require its designated chaperone, Cosmc (43). Although the C1βGal-T and Cosmc genes are located on different chromosomes, Cosmc appears to be specialized for C1βGal-T folding, because the activity of other glycosyltransferases is normal in Cosmc-null Jurkat cells. Interestingly, both C1βGal-T and Cosmc are secretory proteins and form homodimers and thus share a functional similarity with LnbX and LnbY. Another functional homolog is seen in the synthetic pathway of the glycosylphosphatidylinositol anchor. PGI-X has been identified as an important component for active expression of PIG-M, the catalytic subunit of glycosylphosphatidylinositol mannosyltransferase I (44). Interestingly, these chaperone proteins are of similar size (Cosmc (318 aa), PGI-X (252 aa), and LnbY (280 aa)) despite their sequence dissimilarity.
Physiology in HMO Assimilation
By identifying the lnbXY gene, we unequivocally revealed that B. longum JCM1217 extracellularly decomposes LNT by this novel LNBase. The produced LNB and Lac should be imported into the bifidobacterial cells by the GNB/LNB transporter and the Lac transporter, respectively, for further degradation (19, 20, 21) (supplemental Fig. S1). Among the infant gut-associated bifidobacteria, B. bifidum and some strains of B. longum specifically degrade type-1 HMOs by LNBase (LnbB and LnbX, respectively). B. longum LNBase showed lower Km and higher kcat values for LNT than B. bifidum LNBase. Therefore, assuming that the LnbX homolog of B. bifidum does not function within cells (as described above), B. longum can exploit LNT over B. bifidum. This might be an important survival strategy for gut-dwelling B. longum because this subspecies essentially assimilates LNT only among HMOs due to the lack of α-l-fucosidase (12). B. longum might employ its highly active LNBase to sequester LNTs formed from LNFP I and lacto-N-difucohexaose I (the main HMO species) by B. bifidum 1,2-, and 1,3/4-α-l-fucosidases in the gut (13, 15). In this sense, it is interesting that B. bifidum grown in HMO medium ignores the degradation products of HMOs in the spent medium even during the exponential growth phase (12). B. infantis probably circumvents the interception by ingesting all HMOs as intact forms and digesting them intracellularly (23, 24, 25).
Conclusions
Hitherto uncharacterized protein sequences of unknown function, namely BLLJ_1505 and BLLJ_1506, are found to constitute LNBase, an enzyme exhibiting a unique substrate specificity and maturation process. These findings are important not only for comprehensive understanding of HMO assimilation by infant gut bifidobacteria but also in functional glycomics research because B. longum LNBase is the first reported enzyme to liberate GalNAcβ1–3GlcNAc.
Acknowledgment
We thank Yuko Mori for technical assistance.
This work is supported in part by Grants-in-aid for Scientific Research (C) 24580119 and 24580179 from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; a grant-in-aid from the Asahi Glass Foundation; a grant-in-aid from the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); and a grant-in-aid from the Institution for Fermentation, Osaka.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) BK008766.

This article contains supplemental Table S1 and Figs. S1 and S2.
- HMO
- human milk oligosaccharide
- Lac
- lactose
- GH
- glycoside hydrolase
- LacdiNAc
- N,N′-diacetyllactosediamine
- LNB
- lacto-N-biose I
- LNBase
- lacto-N-biosidase
- LNFP
- lacto-N-fucopentaose
- LNT
- lacto-N-tetraose
- LST
- sialyllacto-N-tetraose
- LNnT
- lacto-N-neo-tetraose
- LNH
- lacto-N-hexaose
- LNH
- lacto-N-hexaose
- pNP
- p-nitrophenyl
- aa
- amino acids.
REFERENCES
- 1. Mitsuoka T. (1988) Intestinal flora and host. Asian Med. J. 31, 400–409 [Google Scholar]
- 2. Penders J., Thijs C., Vink C., Stelma F. F., Snijders B., Kummeling I., van den Brandt P. A., Stobberingh E. E. (2006) Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118, 511–521 [DOI] [PubMed] [Google Scholar]
- 3. Kunz C., Rudloff S., Baier W., Klein N., Strobel S. (2000) Oligosaccharides in human milk. Structural, functional, and metabolic aspects. Annu. Rev. Nutr. 20, 699–722 [DOI] [PubMed] [Google Scholar]
- 4. Bode L. (2006) Recent advances on structure, metabolism, and function of human milk oligosaccharides. J. Nutr. 136, 2127–2130 [DOI] [PubMed] [Google Scholar]
- 5. Newburg D. S., Neubauer S. H. (1995) Carbohydrates in milk. in Handbook of Milk Composition (Jensen R. G., ed) pp. 273–349, Academic Press, Inc., New York [Google Scholar]
- 6. Kobata A. (2013) Exo- and endoglycosidases revisited. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 89, 97–117 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Brand-Miller J. C., McVeagh P., McNeil Y., Messer M. (1998) Digestion of human milk oligosaccharides by healthy infants evaluated by the lactulose hydrogen breath test. J. Pediatr. 133, 95–98 [DOI] [PubMed] [Google Scholar]
- 8. Gnoth M. J., Kunz C., Kinne-Saffran E., Rudloff S. (2000) Human milk oligosaccharides are minimally digested in vitro. J. Nutr. 130, 3014–3020 [DOI] [PubMed] [Google Scholar]
- 9. Urashima T., Kitaoka M., Terabayashi T., Fukuda K., Ohnishi M., Kobata A. (2011) Milk oligosaccharides. in Oligosaccharides: Sources, properties and applications (Gordon N. G., ed) pp. 1–58, Nova Science Publishers, New York [Google Scholar]
- 10. Kobata A. (2010) Structures and application of oligosaccharides in human milk. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 86, 731–747 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Sela D. A., Chapman J., Adeuya A., Kim J. H., Chen F., Whitehead T. R., Lapidus A., Rokhsar D. S., Lebrilla C. B., German J. B., Price N. P., Richardson P. M., Mills D. A. (2008) The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proc. Natl. Acad. Sci. U.S.A. 105, 18964–18969 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Asakuma S., Hatakeyama E., Urashima T., Yoshida E., Katayama T., Yamamoto K., Kumagai H., Ashida H., Hirose J., Kitaoka M. (2011) Physiology of consumption of human milk oligosaccharides by infant gut-associated bifidobacteria. J. Biol. Chem. 286, 34583–34592 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Katayama T., Sakuma A., Kimura T., Makimura Y., Hiratake J., Sakata K., Yamanoi T., Kumagai H., Yamamoto K. (2004) Molecular cloning and characterization of Bifidobacterium bifidum 1,2-α-l-fucosidase (AfcA), a novel inverting glycosidase (glycoside hydrolase family 95). J. Bacteriol. 186, 4885–4893 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Nagae M., Tsuchiya A., Katayama T., Yamamoto K., Wakatsuki S., Kato R. (2007) Structural basis on the catalytic reaction mechanism of novel 1,2-α-l-fucosidase (AfcA) from Bifidobacterium bifidum. J. Biol. Chem. 282, 18497–18509 [DOI] [PubMed] [Google Scholar]
- 15. Ashida H., Miyake A., Kiyohara M., Wada J., Yoshida E., Kumagai H., Katayama T., Yamamoto K. (2009) Two distinct α-l-fucosidases from Bifidobacterium bifidum are essential for the utilization of fucosylated milk oligosaccharides and glycoconjugates. Glycobiology 19, 1010–1017 [DOI] [PubMed] [Google Scholar]
- 16. Kiyohara M., Tanigawa K., Chaiwangsri T., Katayama T., Ashida H., Yamamoto K. (2011) An exo-α-sialidase from bifidobacteria involved in the degradation of sialyloligosaccharides in human milk and intestinal glycoconjugates. Glycobiology 21, 437–447 [DOI] [PubMed] [Google Scholar]
- 17. Wada J., Ando T., Kiyohara M., Ashida H., Kitaoka M., Yamaguchi M., Kumagai H., Katayama T., Yamamoto K. (2008) Bifidobacterium bifidum lacto-N-biosidase, a critical enzyme for the degradation of human milk oligosaccharides with a type-1 structure. Appl. Environ. Microbiol. 74, 3996–4004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Miwa M., Horimoto T., Kiyohara M., Katayama T., Kitaoka M., Ashida H., Yamamoto K. (2010) Cooperation of β-galactosidase and β-N-acetylhexosaminidase from bifidobacteria in assimilation of human milk oligosaccharides with type 2 structure. Glycobiology 20, 1402–1409 [DOI] [PubMed] [Google Scholar]
- 19. Kitaoka M., Tian J., Nishimoto M. (2005) Putative galactose operon involving lacto-N-biose phosphorylase in Bifidobacterium longum. Appl. Environ. Microbiol. 71, 3158–3162 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Nishimoto M., Kitaoka M. (2007) Identification of N-acetylhexosamine 1-kinase in the complete lacto-N-biose I/galacto-N-biose metabolic pathway in Bifidobacterium longum. Appl. Environ. Microbiol. 73, 6444–6449 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Suzuki R., Wada J., Katayama T., Fushinobu S., Wakagi T., Shoun H., Sugimoto H., Tanaka A., Kumagai H., Ashida H., Kitaoka M., Yamamoto K. (2008) Structural and thermodynamic analyses of solute-binding protein from Bifidobacterium longum specific for core 1 disaccharide and lacto-N-biose I. J. Biol. Chem. 283, 13165–13173 [DOI] [PubMed] [Google Scholar]
- 22. Xiao J.-Z., Takahashi S., Nishimoto M., Odamaki T., Yaeshima T., Iwatsuki K., Kitaoka M. (2010) Distribution of in vitro fermentation ability of lacto-N-biose I, a major building block of human milk oligosaccharides, in bifidobacterial strains. Appl. Environ. Microbiol. 76, 54–59 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Yoshida E., Sakurama H., Kiyohara M., Nakajima M., Kitaoka M., Ashida H., Hirose J., Katayama T., Yamamoto K, Kumagai H. (2012) Bifidobacterium longum subsp. infantis uses two different β-galactosidases for selectively degrading type-1 and type-2 human milk oligosaccharides. Glycobiology 22, 361–368 [DOI] [PubMed] [Google Scholar]
- 24. Garrido D., Ruiz-Moyano S., Mills D. A. (2012) Release and utilization of N-acetyl-d-glucosamine from human milk oligosaccharides by Bifidobacterium longum subsp. infantis. Anaerobe 18, 430–435 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Sakurama H., Fushinobu S., Hidaka M., Yoshida E., Honda Y., Ashida H., Kitaoka M., Kumagai H., Yamamoto K., Katayama T. (2012) 1,3–1,4-α-l-Fucosynthase that specifically introduces Lewis a/x antigens into type-1/2 chains. J. Biol. Chem. 287, 16709–16719 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Ward R. E., Niñonuevo M., Mills D. A., Lebrilla C. B., German J. B. (2007) In vitro fermentability of human milk oligosaccharides by several strains of bifidobacteria. Mol. Nutr. Food Res. 51, 1398–1405 [DOI] [PubMed] [Google Scholar]
- 27. Fukuda S., Toh H., Hase K., Oshima K., Nakanishi Y., Yoshimura K., Tobe T., Clarke J. M., Topping D. L., Suzuki T., Taylor T. D., Itoh K., Kikuchi J., Morita H., Hattori M., Ohno H. (2011) Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469, 543–547 [DOI] [PubMed] [Google Scholar]
- 28. Ito T., Katayama T., Hattie M., Sakurama H., Wada J., Suzuki R., Ashida H., Wakagi T., Yamamoto K., Stubbs K. A., Fushinobu S. (2013) Crystal structures of a glycoside hydrolase family 20 lacto-N-biosidase from Bifidobacterium bifidum. J. Biol. Chem. 288, 11795–11806 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Honda Y., Nishimoto M., Katayama T., Kitaoka M. (2013) Characterization of the cytosolic β-N-acetylglucosaminidase from Bifidobacterium longum subsp. longum. J. Appl. Glycosci., in press [Google Scholar]
- 30. Yoshida-Moriguchi T., Yu L., Stalnaker S. H., Davis S., Kunz S., Madson M., Oldstone M. B., Schachter H., Wells L., Campbell K. P. (2010) O-Mannosyl phosphorylation of α-dystroglycan is required for laminin binding. Science 327, 88–92 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Nishimoto M., Kitaoka M. (2007) Practical preparation of lacto-N-biose I, the candidate of the bifidus factor in human milk. Biosci. Biotechnol. Biochem. 71, 2101–2104 [DOI] [PubMed] [Google Scholar]
- 32. Inaba T., Ohgushi T., Iga Y., Hasegawa E. (1984) Synthesis of 4-methylcoumarin-7-yloxy tetra-N-acetyl-β-chitotetraoside, a novel synthetic substrate for the fluorometric assay of lysozyme. Chem. Pharm. Bull. 32, 1597–1603 [Google Scholar]
- 33. Matsumura H., Takeuchi A., Kano Y. (1997) Construction of Escherichia coli-Bifidobacterium longum shuttle vector transforming B. longum 105-A and 108-A. Biosci. Biotechnol. Biochem. 61, 1211–1212 [DOI] [PubMed] [Google Scholar]
- 34. Hirayama Y., Sakanaka M., Fukuma H., Murayama H., Kano Y., Fukiya S., Yokota A. (2012) Development of a double-crossover markerless gene deletion system in Bifidobacterium longum. Functional analysis of the α-galactosidase gene for raffinose assimilation. Appl. Environ. Microbiol. 78, 4984–4994 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Punta M., Coggill P. C., Eberhardt R. Y., Mistry J., Tate J., Boursnell C., Pang N., Forslund K., Ceric G., Clements J., Heger A., Holm L., Sonnhammer E. L., Eddy S. R., Bateman A., Finn R. D. (2012) The Pfam protein families database. Nucleic Acids Res. 40, D290–D301 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Petersen T. N., Brunak S., von Heijne G., Nielsen H. (2011) SignalP 4.0. Discriminating signal peptides from transmembrane regions. Nat. Methods 8, 785–786 [DOI] [PubMed] [Google Scholar]
- 37. Sano M., Hayakawa K., Kato I. (1992) An enzyme releasing lacto-N-biose from oligosaccharides. Proc. Natl. Acad. Sci. U.S.A. 89, 8512–8516 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Hiruma T., Togayachi A., Okamura K., Sato T., Kikuchi N., Kwon Y.-D., Nakamura A., Fujimura K., Gotoh M., Tachibana K., Ishizuka Y., Noce T., Nakanishi H., Narimatsu H. (2004) A novel human β1,3-N-Acetylgalactosaminyltransferase that synthesizes a unique carbohydrate structure, GalNAcβ1–3GlcNAc. J. Biol. Chem. 279, 14087–14095 [DOI] [PubMed] [Google Scholar]
- 39. Stevens E., Carss K. J., Cirak S., Foley A. R., Torelli S., Willer T., Tambunan D. E., Yau S., Brodd L., Sewry C. A., Feng L., Haliloglu G., Orhan D., Dobyns W. B., Enns G. M., Manning M., Krause A., Salih M. A., Walsh C. A., Hurles M., Campbell K. P., Manzini M. C., UK10K Consortium, Stemple D., Lin Y. Y., Muntoni F. (2013) Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan. Am. J. Hum. Genet. 92, 354–365 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Woodworth A., Fiete D., Baenziger J. U. (2002) Spatial and temporal regulation of tenascin-R glycosylation in the cerebellum. J. Biol. Chem. 277, 50941–50947 [DOI] [PubMed] [Google Scholar]
- 41. Wuhrer M., Koeleman C. A., Deelder A. M., Hokke C. H. (2006) Repeats of LacdiNAc and fucosylated LacdiNAc on N-glycans of the human parasite Schistosoma mansoni. FEBS J. 273, 347–361 [DOI] [PubMed] [Google Scholar]
- 42. Sasaki N., Shinomi M., Hirano K., Ui-Tei K., Nishihara S. (2011) LacdiNAc (GalNAcβ1–4GlcNAc) contributes to self-renewal of mouse embryoic stem cells by regulating leukemia inhibitory factor/STAT3 signaling. Stem Cells 29, 641–650 [DOI] [PubMed] [Google Scholar]
- 43. Ju T., Cummings R. D. (2002) A unique molecular chaperon Cosmc required for activity of the mammalian core 1 β3-galactosyltransferase. Proc. Natl. Acad. Sci. U.S.A. 99, 16613–16618 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Ashida H., Hong Y., Murakami Y., Shishioh N., Sugimoto N., Kim Y. U., Maeda Y., Kinoshita T. (2005) Mammalian PIG-X and yeast Pbn1p are the essential components of glycosylphosphatidylinositol-mannosyltransferase I. Mol. Biol. Cell 16, 1439–1448 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Anderson K., Li S. C., Li Y. T. (2000) Diphenylamine-aniline-phosphoric acid reagent, a versatile spray reagent for revealing glycoconjugates on thin-layer chromatography plates. Anal. Biochem. 287, 337–339 [DOI] [PubMed] [Google Scholar]




